Read the latest and past features

People living with more severe psoriasis are at a greater risk of developing psoriatic arthritis (PsA), an inflammatory condition that affects the joints. Understanding this connection is important, as early and effective treatment for psoriasis may help reduce the risk of PsA.

Today, Wednesday, 29 October,  marks World Psoriasis Day 2025, where millions of people across the globe unite in recognition of the challenges faced by those living with psoriasis and psoriatic arthritis. As the official UK member of IFPA, we support this year's theme: "Psoriatic Disease and Comorbidities – Understanding the Domino Effect."​

Historically, most of the approaches to treating psoriasis have focused on inhibiting the actions of pro-inflammatory immune cells, i.e. the cells causing the inflammatory response.

This lively new edition explores the surprising role of fungal infections in psoriasis. Almost 1 in 6 patients in a recent study carried a hidden infection, often making their skin worse and harder to treat.

If you or someone you know is living with psoriasis or psoriatic arthritis, you’ve probably heard about biologic treatments, those breakthrough drugs that have changed the game for many managing these conditions. But what about biosimilars the “generic” versions of biologics? Are they the same? Different?

Living with psoriatic disease, whether psoriasis or psoriatic arthritis, often means managing multiple appointments, treatments, and specialists. You may have heard that the NHS is increasingly “outsourcing” some services and wondered what that means for your care.

Understanding the bigger picture is key to managing psoriasis well and protecting overall health. For most people, it is often mild, but there lurks some other, often missed associated conditions.

High temperatures can affect how well your medicines work and may even make them unsafe. This is especially important for those managing psoriasis or psoriatic arthritis.

It’s a turbulent time, with the world having seen significant changes, raising questions for the UK, especially for patients and healthcare innovation.

With the UK and much of Europe in the grip of a heatwave, many of us are feeling the heat in more ways than one.